Klaria Pharma Holding AB (publ.)

kr 0.52As of Sun 8 Nov 2026, 12:00 UTC
STO:KLARHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (22.85%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 1.31
PE TTM —
TSR TTM 7.39%
Mkt cap kr 128.6M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 0.676
29.17%
4.90%
Hold 5|8|8|3|11
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.01
0.01
0.01
0.01
10.15%
0.13%
9.53%
1.47%
Revenuekr M
6.945
7.288
7.431
7.244
0.22%
8.09%
10.66%
8.81%
Peers (US$13.01M)
Cap (US$)
PE
7.846M
—
Capital
TTM
5Y
10Y
Leveragex
0.793
0.561
0.478
EBIT/Intx
2.117
0.408
0.436
Own earn%
(68.41)
52.88
59.42
Sh yield%
13.51
19.01
19.02
Owners
Insiders/Inst%
11.58
22.59
Short interest%
4.50
SBC / revenue%
0.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
27–35
$1 testx
—
Incr. ROIC%
6